The document discusses various areas of neurotechnology research being conducted by Team Neuroscience including biomarkers for disease detection, brain-computer interfaces, and applications of neuroscience to understand consumer behavior and optimize team performance. Specific areas mentioned include diagnostic systems for sleep disorders, biomarkers for Alzheimer's disease, rehabilitation for conditions like stroke and spinal cord injury using brain-computer interfaces, and using EEG metrics to study audience responses and team leadership qualities.
5. Over
300,000 OSA patients
have been diagnosed in the comfort
of their homes with ARES, the top
selling OSA diagnosis system in the US
6. APNEA
GUARD®
NIGHT
SHIFT ™
Innovations in sleep continue providing novel therapies for OSA and diagnosing and treating insomnia— Medical efficacy in the privacy of your home
SLEEP PROFILER™
9. 2014 Costs of Alzheimer's
$214 Billion
More than 5 million Americans are living with Alzheimer’s Disease
There is an unmet need for early detection and treatment outcome biomarkers
10. Benefits over traditional neuroimaging biomarkers:
•Non-invasive
•Unobtrusive
•Cost-effective
•Comfortable
•Easy to apply
11. ABM is partnering to provide biomarkers for next generation diagnostics and treatment.
35. •ISO 13485 and FDA Device Manufacturer
•Recipient of over $32 mm in government R&D funding
•Diversified revenues through commercialization of devices and software, partnerships, and leading clinical trials
•Inc. 5000 Fastest Growing 2008-2013 (5 consecutive years)
•16 patents issued; 13 patents-pending
•70+ papers validating suite of technologies
•Customers include Fortune 500, military & government labs and leading universities
•Global distribution network established in EU, Asia, Australia